ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA
· Real-Time Price · USD
4.47
0.03 (0.68%)
At close: Aug 15, 2025, 12:08 PM
ENDRA Life Sciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.55 | -0.2 | -0.84 | -31.11 | -108.52 | -1.09K | -267.51 | -409.1 | -656.4 | -1.05K | -1.49K | -1.09K | -0.00 | -4.09K | -11.93K | -12.42K | -18.93K |
PEG Ratio | 0.01 | -0.00 | -0.01 | 1.58 | -1.18 | 20.36 | -12.54 | 208.64 | 69.33 | 188.39 | 348.84 | 10.91 | -0.00 | -247.1 | 680.66 | -438.52 | 523.47 |
PS Ratio | n/a | 15.88 | n/a | n/a | n/a | 14.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.30 | 1.31 | 1.20 | 30.84 | 325.80 | 1.12K | 638.54 | 603.78 | 1.72K | 1.91K | 2.03K | 1.18K | 3.24K | 4.71K | 9.64K | 10.61K | 9.63K |
P/FCF Ratio | -1.74 | -2.22 | -4.77 | -133.85 | -554.89 | -2.9K | -1.28K | -1.84K | -3.05K | -4.4K | -6.34K | -4.64K | -9.22K | -19.13K | -46.2K | -56.8K | -57.9K |
P/OCF Ratio | -1.77 | -2.22 | -4.77 | -133.14 | -561.88 | -2.91K | -1.28K | -1.84K | -3.09K | -4.45K | -6.37K | -4.72K | -9.48K | -19.13K | -46.2K | -56.8K | -58.79K |
OCF/S Ratio | n/a | -7.16 | n/a | n/a | n/a | -5.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.34 | 0.23 | 0.04 | 0.03 | 0.09 | 0.07 | 0.08 | 0.07 | 0.11 | 0.08 | 0.06 | 0.05 | 0.07 | 0.06 | 0.05 | 0.05 | 0.02 |
Quick Ratio | 3.85 | 5.67 | 6.10 | 4.97 | -1.18 | 0.45 | 1.68 | 2.62 | 1.52 | 3.45 | 5.24 | 8.06 | 6.03 | 7.00 | 8.23 | 9.17 | 23.01 |
Current Ratio | 3.85 | 5.67 | 6.10 | 4.97 | 1.04 | 3.36 | 2.95 | 3.98 | 3.01 | 5.00 | 6.78 | 9.64 | 7.45 | 7.83 | 9.18 | 9.98 | 23.96 |
Asset Turnover | n/a | 0.05 | n/a | n/a | n/a | 0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -859.96 | n/a | -148.5 | -184.35 | -0.00 | n/a | n/a | n/a | n/a |
Return on Equity | -0.59 | -1.62 | -0.36 | -0.25 | -0.75 | -0.26 | -0.6 | -0.37 | -0.65 | -0.45 | -0.34 | -0.27 | -315.17K | -0.29 | -0.2 | -0.21 | -0.13 |
Return on Assets | -0.33 | -0.93 | -0.28 | -0.21 | -0.55 | -0.22 | -0.41 | -0.28 | -0.44 | -0.35 | -0.28 | -0.24 | -261.34K | -0.24 | -0.17 | -0.19 | -0.12 |
Return on Invested Capital | n/a | -1.09 | -0.19 | -0.24 | -0.66 | -0.24 | -0.56 | -0.4 | -0.59 | -0.42 | -0.31 | -0.25 | -289.79K | -0.26 | -0.19 | -0.2 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | 0.00 | 0.00 | n/a | n/a | 0.00 | 0.00 | n/a | n/a | 0.00 |
Payout Ratio | n/a | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | -0.00 | -0.00 | n/a | n/a | -0.00 | -0.04 | n/a | n/a | -0.05 |
Gross Profit Margin | n/a | 0.50 | n/a | n/a | n/a | 0.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -19.61 | n/a | n/a | n/a | -3.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -19.61 | n/a | n/a | n/a | -3.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -20.31 | n/a | n/a | n/a | -3.4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -20.09 | n/a | n/a | n/a | -3.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |